Search - tctmd.com

Displaying 121 - 137 of 137

Sort: Relevancy | Date

News Conference News TCT 2013

Experts Discuss Efficacy, Safety of Watchman Device

October 28, 2013

Presentation TCT 2013

Watchman

Presenter: Saibal Kar

October 27, 2013

Presentation TCT 2013

Deep Dive of the Watchman Data: PROTECT AF, CAP AND PREVAIL Safety Issues

Presenter: Saibal Kar

October 27, 2013

Presentation TCT 2013

The MitraClip Procedure For Functional Mitral Regurgitation Results In A Significant Change In Procedural Hemodynamics.

Presenter: Wen Loong Yeow, Mamoo Nakamura, Takashi Matsumoto, Hasan Jilaihawi, Asma Hussaini, Moody Makar, Swaminatha V. Gurudevan, Robert Siegel, Saibal Kar

January 31, 2013

Presentation TCT 2013

Procedural success is improved with a 2nd MitraClip placement without additional complications.

Presenter: Takashi Matsumoto, Wen Loong Yeow, Asma Hussaini, Mamoo Nakamura, Moody Makar, Swaminatha V. Gurudevan, Robert Siegel, Saibal Kar

January 31, 2013

Presentation TCT 2013

Large 22 to 24Fr femoral vein hemostasis with a subcutaneous stitch or a double Perclose closure is effective and safe.

Presenter: Asma Hussaini, Wen Loong Yeow, Takashi Matsumoto, Mamoo Nakamura, Hassan Jlaihawi, Raj Makkar, Saibal Kar

January 31, 2013

Presentation TCT 2013

Effectiveness of Transcatheter Mitral Valve Repair in Degenerative Mitral Regurgitation in High Surgical Risk Patients

Presenter: D. Scott Lim, Saibal Kar, Patrick Whitlow, Michael Argenziano, Alfredo Trento, Gorav Ailawadi, Donald Glower, Ted Feldman

January 31, 2013

Presentation TCT 2012

The Expert MitraClip Procedure: From Transseptal Puncture to Echocardiographic Guidance and Procedural Tips and Tricks

Presenter: Saibal Kar

October 26, 2012

News Conference News TCT 2012

Presentation TCT 2012

WaveCrest (Coherex Medical): Device Iteration, Human Outcomes, and Clinical Trial Directions

Presenter: Saibal Kar

October 23, 2012

Presentation TCT 2012

TCT-84. Watchman Left Atrial Appendage Closure in Atrial Fibrillation Patients 75 Years or Greater; A Sub-Analysis of the PROTECT AF Study

Presenter: Saibal Kar

October 23, 2012

Presentation TCT 2012

Prevail Study: Design and Current Status

Presenter: Saibal Kar

October 23, 2012

Presentation TCT 2012

Why You Need a Multidisciplinary Heart Team: Case Scenario 2: Transcatheter Mitral Valve Repair

Presenter: Saibal Kar

October 22, 2012

Presentation TCT 2012

EVEREST II High Surgical Risk Cohort: Clinical Benefit by MR Grade in High Surgical Risk Patients One Year Following MitraClip Therapy.

Presenter: Paul Grayburn, Saibal Kar, Ted Feldman, Donald Glower, Elyse Foster, Laura Mauri

January 03, 2012

Presentation TCT 2012

Effectiveness of Percutaneous Reduction of Significant Mitral Regurgitation of Functional Etiology in High Surgical Risk Patients.

Presenter: Michael Argenziano, William Gray, Alfredo Trento, Saibal Kar, Elyse Foster, Laura Mauri, Ted Feldman, Donald Glower

January 03, 2012

Advertisement

Experts Discuss Efficacy, Safety of Watchman Device

Watchman

Deep Dive of the Watchman Data: PROTECT AF, CAP AND PREVAIL Safety Issues

The MitraClip Procedure For Functional Mitral Regurgitation Results In A Significant Change In Procedural Hemodynamics.

Procedural success is improved with a 2nd MitraClip placement without additional complications.

Large 22 to 24Fr femoral vein hemostasis with a subcutaneous stitch or a double Perclose closure is effective and safe.

Effectiveness of Transcatheter Mitral Valve Repair in Degenerative Mitral Regurgitation in High Surgical Risk Patients

The Expert MitraClip Procedure: From Transseptal Puncture to Echocardiographic Guidance and Procedural Tips and Tricks

Watchman LAA Effective in Patients Contraindicated for Warfarin

Novel Devices Provide Options for LAA Therapy

Case 2: Optimal Transseptal Puncture for the MitraClip

WaveCrest (Coherex Medical): Device Iteration, Human Outcomes, and Clinical Trial Directions

TCT-84. Watchman Left Atrial Appendage Closure in Atrial Fibrillation Patients 75 Years or Greater; A Sub-Analysis of the PROTECT AF Study

Prevail Study: Design and Current Status

Why You Need a Multidisciplinary Heart Team: Case Scenario 2: Transcatheter Mitral Valve Repair

EVEREST II High Surgical Risk Cohort: Clinical Benefit by MR Grade in High Surgical Risk Patients One Year Following MitraClip Therapy.

Effectiveness of Percutaneous Reduction of Significant Mitral Regurgitation of Functional Etiology in High Surgical Risk Patients.

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content